Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using the Internet to calculate clinical action thresholds.

I Hozo1, B Djulbegovic

  • 1Department of Mathematics, Indiana University Northwest, Gary 46408, USA.

Computers and Biomedical Research, an International Journal
|May 25, 1999
PubMed
Summary

Physicians can now calculate treatment threshold probabilities using efficacy and risk data. A new online tool integrates treatment efficacy, harms, and NNT for better clinical decision-making and quantitative benefit-risk analysis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of the quality of life between HIV-positive haemophilia patients and HIV-negative haemophilia patients.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review.

Bone marrow transplantation·2015
Same author

Soluble P-selectin glycoprotein ligand - a possible new target in ulcerative colitis.

Bratislavske lekarske listy·2015
Same author

High-dose therapy and autologous hematopoietic cell transplantation as front-line consolidation in chronic lymphocytic leukemia: a systematic review.

Bone marrow transplantation·2015
Same author

Comparing efficacy of reduced-toxicity allogeneic hematopoietic cell transplantation with conventional chemo-(immuno) therapy in patients with relapsed or refractory CLL: a Markov decision analysis.

Bone marrow transplantation·2012
Same author

Antithymocyte globulin for acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic review.

Leukemia·2011

Area of Science:

  • Clinical Decision Making
  • Medical Informatics
  • Health Services Research

Background:

  • Clinical practice relies on understanding treatment risks and benefits.
  • Previous models for treatment decisions were limited by data availability.
  • Net benefits and risks are crucial for treatment and diagnostic test decisions.

Purpose of the Study:

  • To develop a model for calculating treatment threshold probabilities using readily available data.
  • To create an accessible tool for physicians to perform benefit-risk analysis.
  • To facilitate wider adoption of quantitative benefit-risk analysis in clinical practice.

Main Methods:

  • Derived equations for treatment threshold probability using treatment efficacy (E) and risk (Rrx) data.
  • Developed a JavaScript-based online calculator for threshold probability computation.

Related Experiment Videos

  • Integrated evidence-based summary measures like efficacy, harms, and Number Needed to Treat (NNT).

    • Main Results:

    • Established a method to calculate treatment thresholds from efficacy and risk data.
    • Created an accessible internet-based tool for physicians.
    • Demonstrated that diagnostic tests are warranted only when disease probability falls between testing and treatment thresholds.

    Conclusions:

    • Quantitative benefit-risk analysis can be effectively integrated into clinical decision-making models.
    • The developed online tool simplifies the calculation of threshold probabilities for everyday clinical use.
    • Physicians can make more informed decisions by considering treatment efficacy, risks, and NNT.